Controversies in Neuro-Oncology

Controversies in Neuro-Oncology

ISSN: 2210-5565 (Online)

Introduction

Neuro-oncology is an embryonic field of cancer research with a number of clinical trials in progress. However, the prognosis on neuro-oncologic patients has remained poor. Moreover, several small scale phase I/II trials performed have proved to be inconclusive because of the limited number of patients involved. As a result, many controversies exist in neuro-oncology drug development for which a forum does not exist. This ebook presents a detailed account on the use of avastin in treating cancer patients. A discussion on clinical experiences and the controversial debate among researchers of avastin's role in restricting malignant gliomas is also included giving readers a diverse perspective on the rationale of treating CNS tumors.






Published Volumes in Series


Avastin and Malignant Gliomas

Avastin and Malignant Gliomas

Volume 1 (Thomas C. Chen)

ISSN: 2210-5565 (Print)

ISBN: 978-1-60805-132-8 (Online)

ISBN: 978-1-60805-519-7 (Print)

Card List Article

This ebook presents a detailed account on the use of avastin in treating cancer patients. A discussion on clinical experiences and the controversial debate among researchers of avastin’s role in restricting malignant gliomas is also included giving readers a diverse perspective on the rationale of treating CNS tumors.

eBook: US $79 Special Offer (PDF + Printed Copy): US $158
Printed Copy: US $119
Library License: US $316